Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Dubai’s real-estate market continues to surge, with total transactions exceeding AED 326 billion in the first half of 2025, marking a 39 percent increase compared with the same period last year. According to data from the Dubai Land Department, more than 118,000 property deals were completed by 94,700 investors, reflecting broad confidence in the emirate’s […] The post Dubai Real Estate Surges Past AED 326 Billion in H1 2025 says Arabian Gulf Properties Highlighting Drivers of Sustained Growth appeared first on Web-Release.